Title: Dose escalation pharmacokinetics and lipid lowering activity of a novel farnesoid X receptor modulator: 16-Dehydropregnenolone.
Journal: Indian journal of pharmacology 20120101
Title: A Validated Reverse Phase HPLC Analytical Method for Quantitation of Glycoalkaloids in Solanum lycocarpum and Its Extracts.
Journal: Journal of analytical methods in chemistry 20120101
Title: Activation of ATM-Chk2 by 16-dehydropregnenolone induces G1 phase arrest and apoptosis in HeLa cells.
Journal: Journal of Asian natural products research 20120101
Title: Aza-annulation on the 16-dehydropregnenolone, via tandem intermolecular aldol process and intramolecular Michael addition.
Journal: Bioorganic & medicinal chemistry letters 20110415
Title: Preclinical pharmacokinetics, dose proportionality, gender difference and protein binding study of 16-dehydropregnenolone, an antihyperlipidemic agent, in rats.
Journal: The Journal of pharmacy and pharmacology 20110101
Title: In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
Journal: The Journal of steroid biochemistry and molecular biology 20080901
Title: Cytotoxic constituents from Solanum lyratum.
Journal: Archives of pharmacal research 20060201
Title: A sensitive and selective HPLC/ESI-MS/MS assay for the simultaneous quantification of 16-dehydropregnenolone and its major metabolites in rabbit plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060102
Title: Synthesis of some new steroidal [16alpha,17alpha-d]-isoxazolines.
Journal: Steroids 20050701
Title: HPLC-UV method development and validation for 16-dehydropregnenolone, a novel oral hypolipidaemic agent, in rat biological matrices for application to pharmacokinetic studies.
Journal: Journal of pharmaceutical and biomedical analysis 20031124
Title: Development of an enzyme immunoassay for serum 16-dehydropregnenolone.
Journal: Biological & pharmaceutical bulletin 20010801
